Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berent

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Forensic Science International|November 18, 1997
A D5S43 (MS8) allele with an internal Hae III restriction siteE Raczek, J A Berent
European Journal of Vascular Surgery|December 1, 1988
The use of the selective serotonin S2 receptor antagonist Ketanserin in the treatment of Raynaud's phenomenonJ A Dormandy, A Berent, S J Downes
La Ricerca in Clinica E in Laboratorio|January 1, 1981
Is haemodilution a good thing?J A Dormandy, C J Yates, A Berent
Angiology|April 1, 1981
Clinical relevance of blood viscosity and red cell deformability including newer therapeutic aspectsJ A Dormandy, C J Yates, G A Berent
International Journal of Legal Medicine|January 1, 1997
The STR systems FES/FPS and F13B in a Polish populationJ Janica, W Pepinski, M Skawronska, et al.
Lancet (London, England)|July 28, 1979
Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudicationC J Yates, A Berent, V Andrews, et al.
Lancet (London, England)|December 7, 1985
Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudicationH Bounameaux, T Holditch, H Hellemans, et al.
International Journal of Legal Medicine|November 7, 1999
Population genetics of the STRs vWA, D3S1358 and FGA in the Pomerania-Kujawy region of PolandD Miścicka-Sliwka, J Czarny, J A Berent, et al.
Journal of Addictions Nursing|December 17, 2014
Yoga as an alternative intervention for promoting a healthy lifestyle among college studentsGeorgine R Berent, Jeanne-Marie Zeck, Julia A Leischner, et al.
British Medical Journal|May 6, 1978
Symptomatic and objective effects of venesection on patients with intermittent claudicationT F Ford, A Berent, K Speed, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Forensic Science International|November 18, 1997
A D5S43 (MS8) allele with an internal Hae III restriction siteE Raczek, J A Berent
European Journal of Vascular Surgery|December 1, 1988
The use of the selective serotonin S2 receptor antagonist Ketanserin in the treatment of Raynaud's phenomenonJ A Dormandy, A Berent, S J Downes
La Ricerca in Clinica E in Laboratorio|January 1, 1981
Is haemodilution a good thing?J A Dormandy, C J Yates, A Berent
Angiology|April 1, 1981
Clinical relevance of blood viscosity and red cell deformability including newer therapeutic aspectsJ A Dormandy, C J Yates, G A Berent
International Journal of Legal Medicine|January 1, 1997
The STR systems FES/FPS and F13B in a Polish populationJ Janica, W Pepinski, M Skawronska, et al.
Lancet (London, England)|July 28, 1979
Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudicationC J Yates, A Berent, V Andrews, et al.
Lancet (London, England)|December 7, 1985
Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudicationH Bounameaux, T Holditch, H Hellemans, et al.
International Journal of Legal Medicine|November 7, 1999
Population genetics of the STRs vWA, D3S1358 and FGA in the Pomerania-Kujawy region of PolandD Miścicka-Sliwka, J Czarny, J A Berent, et al.
Journal of Addictions Nursing|December 17, 2014
Yoga as an alternative intervention for promoting a healthy lifestyle among college studentsGeorgine R Berent, Jeanne-Marie Zeck, Julia A Leischner, et al.
British Medical Journal|May 6, 1978
Symptomatic and objective effects of venesection on patients with intermittent claudicationT F Ford, A Berent, K Speed, et al.
Pageof 2